EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level

Yulia Kirdeeva iD, Elizaveta Fefilova, Natalia Karpova iD, Sergey Parfenyev, Alexandra Daks iD, Alexander Nazarov, Oleg Semenov iD, Nguyen Thi Van Anh, Vu Thanh Loc iD, Nguyen Manh Cuong iD, Oleg Shuvalov iD

International Journal of Molecular Sciences · 28.01.2026 · 27 (3) · 1312

DOI: 10.3390/ijms27031312 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.01.2026. Verfasst von Yulia Kirdeeva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cytology, Russian Academy of Sciences, 194064 St. Petersburg, Russia. Hauptthemen laut MEDLINE: Agaricales, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 381 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RSF-VAST joint grant, RSF, VAST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mushrooms are valued for their nutritional qualities and have been used in traditional medicine since the Neolithic era. They exhibit various bioactivities, including antioxidant, hypocholesterolemic, immunomodulatory, and anticancer effects. The anticancer effects arise via direct action on tumor cells and indirect modulation of the immune system; the latter is the predominant mechanism. Numerous studies indicate that various mushroom species are potent immunostimulants because their cell wall polysaccharides and proteoglycans are recognized by intestinal immune cells. This enhances antitumor immunity through multiple molecular pathways. However, their direct effects on cancer cells are of questionable physiological relevance due to bioavailability constraints. Nevertheless, we hypothesize that the accumulation of non-absorbed polysaccharides in the gastrointestinal tract positions mushrooms as dual-action agents with the potential to treat colorectal cancer by providing indirect immunomodulation and direct local tumor suppression. Conversely, the direct anticancer effects of mushrooms are generally attributed to bioactive secondary metabolites that influence essential cellular processes, including signaling pathways, cell cycle regulation, apoptosis, autophagy, cellular migration, invasion, and cancer stem cell characteristics. Beyond these anticancer effects, clinical evidence suggests that certain mushroom-derived substances can improve survival outcomes for cancer patients and provide supportive care benefits in oncology, thereby improving quality of life. Specifically, mushrooms may mitigate the side effects of chemotherapy and radiotherapy, bolster immune function often suppressed by cancer treatments, and enhance overall well-being. In this review, we discuss the therapeutic benefits of dietary and medicinal mushrooms in cancer care, as well as unresolved challenges and future research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgaricalesNeoplasmsAntineoplastic AgentsHumansAnimalsTranslational Research, BiomedicalImmunomodulation

Stichwörter der Autor:innen

immunomodulationlow-molecular-weight compoundsmushroompolysaccharidessignaling pathwaysβ-glucans

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Institute of Cytology, Russian Academy of Sciences, 194064 St. Petersburg, Russia.
  • Department of Life Sciences, University of Science and Technology of Hanoi, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Nghia Do, Hanoi 11353, Vietnam.
  • Center for Development of Natural Products and Technology-Equipments, Institute of Chemistry, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Nghia Do, Hanoi 11353, Vietnam.

ORCID-Profile: Yulia Kirdeeva, Natalia Karpova, Alexandra Daks, Oleg Semenov, Vu Thanh Loc, Nguyen Manh Cuong, Oleg Shuvalov

Förderung

  • RSF-VAST joint grant
  • RSF
  • VAST

Zitieren

APA

Kirdeeva, Y., Fefilova, E., Karpova, N., Parfenyev, S., Daks, A., Nazarov, A., Semenov, O., Anh, N. T. V., Loc, V. T., Cuong, N. M., & Shuvalov, O. (2026). The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level. International Journal of Molecular Sciences, 27(3), 1312. https://doi.org/10.3390/ijms27031312

Vancouver

Kirdeeva Y, Fefilova E, Karpova N, Parfenyev S, Daks A, Nazarov A, et al. The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level. International Journal of Molecular Sciences. 2026;27(3):1312. doi:10.3390/ijms27031312

BibTeX
@article{Kirdeeva2026,
  author = {Kirdeeva, Yulia and Fefilova, Elizaveta and Karpova, Natalia and Parfenyev, Sergey and Daks, Alexandra and Nazarov, Alexander and Semenov, Oleg and Anh, Nguyen Thi Van and Loc, Vu Thanh and Cuong, Nguyen Manh and Shuvalov, Oleg},
  title = {The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {3},
  pages = {1312},
  doi = {10.3390/ijms27031312}
}
Kostenlos starten →